Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ADVANCED SOLID TUMORS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02748837
What this trial is testing

ERY974 in Patient With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Chugai Pharmaceutical 29
Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Early research (Phase 1)Study completedNCT02354898
What this trial is testing

BBI503 in Advanced Solid Tumors, or BBI503/ Sorafenib in Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Solid TumorsHepatocellular Carcinoma
Sumitomo Pharma Co., Ltd. 60
Early research (Phase 1)WithdrawnNCT00601614
What this trial is testing

Vandetanib and Temozolomide in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Mayo Clinic
Testing effectiveness (Phase 2)Looking for participantsNCT06117540
What this trial is testing

WX390 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Shanghai Jiatan Pharmatech Co., Ltd 70
Early research (Phase 1)Active Not RecruitingNCT05914376
What this trial is testing

Safety of Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Tumors

Who this might be right for
Advanced Solid Tumors
Hangzhou Converd Co., Ltd. 24
Early research (Phase 1)Study completedNCT00849550
What this trial is testing

Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.

Who this might be right for
Unspecified Adult Solid Tumor, Protocol SpecificCancer
Herbert Hurwitz 32
Early research (Phase 1)Study completedNCT04261413
What this trial is testing

Phase Ia/Ib Study of RS-0139 in Patients With a Recurrent, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
RS Arastirma Egitim Danismanlik Ilac Sanayi Ticaret A.S. 16
Not applicableStudy completedNCT02724488
What this trial is testing

Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies

Who this might be right for
Head and Neck CancerMelanoma
University Health Network, Toronto 14
Early research (Phase 1)Study completedNCT05085548
What this trial is testing

ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies

Who this might be right for
Advanced Pancreatic CancerSolid Tumor Malignancies
ProDa BioTech, LLC 46
Early research (Phase 1)Study completedNCT00054548
What this trial is testing

Combination Chemotherapy Plus Oblimersen in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Looking for participantsNCT05367778
What this trial is testing

Phase 1/2 Study of HS-10370 in Patients with Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Jiangsu Hansoh Pharmaceutical Co., Ltd. 176
Testing effectiveness (Phase 2)Looking for participantsNCT05379985
What this trial is testing

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
Revolution Medicines, Inc. 754
Early research (Phase 1)Study completedNCT02355535
What this trial is testing

Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1

Who this might be right for
Solid TumorPancreatic Neuroendocrine TumorNeuroendocrine Tumors
Vanquish Oncology, Inc. 48
Early research (Phase 1)Ended earlyNCT04729725
What this trial is testing

SAR439459 and Cemiplimab for the Treatment of Advanced or Unresectable Solid Tumors, Strategic Alliance, TACTIC TRIAL

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm
M.D. Anderson Cancer Center 3
Early research (Phase 1)Study completedNCT00880308
What this trial is testing

Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor CancersMedulloblastomaBasal Cell Carcinoma
Novartis Pharmaceuticals 103
Early research (Phase 1)Study completedNCT00400023
What this trial is testing

A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid Tumors

Who this might be right for
Tumors
Taiho Oncology, Inc. 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439123
What this trial is testing

Testing AZD5363 as a Potential Targeted Treatment in Cancers With AKT Genetic Changes (MATCH-Subprotocol Y)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT00622674
What this trial is testing

Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+5 more
Masonic Cancer Center, University of Minnesota 37
Testing effectiveness (Phase 2)Looking for participantsNCT06682780
What this trial is testing

A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours

Who this might be right for
Advanced Solid Tumor
LaNova Medicines Limited 320
Next Page